Dr Reddys Laboratories (RDY) Free Cash Flow (2009)
Dr Reddys Laboratories (RDY) posted quarterly Free Cash Flow of $177.0 million for Q4 2009, down 28.92% quarter-over-quarter from $249.0 million in Q3 2009.
Dr Reddys Laboratories (RDY) Free Cash Flow (2009) Analysis & Trends
Dr Reddys Laboratories' Free Cash Flow history runs 1 years deep, the most recent figure standing at $177.0 million for Q4 2009.
- In Q4 2009, Free Cash Flow changed N/A year-over-year to $177.0 million; the TTM figure through Sep 2010 stood at $177.0 million (down 58.95% YoY), while the FY2026 annual figure was $358.0 million, up 60.54% from the prior year.
- Free Cash Flow for Q4 2009 stood at $177.0 million, down from $249.0 million in the prior quarter.
- The five-year high for Free Cash Flow was $249.0 million in Q3 2009, with the low at $177.0 million in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | 137.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | 177.00 Mn |
| Dec 31, 2009 | 177.00 Mn |
| Sep 30, 2009 | 249.00 Mn |
| Sep 30, 2009 | 249.00 Mn |
| Jun 30, 2009 | 200.00 Mn |
| Jun 30, 2009 | 200.00 Mn |